The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 5.00 (20.00%)
Open: 27.50
High: 27.50
Low: 27.50
Prev. Close: 27.50
KRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Apr 2020 07:00

RNS Number : 5012I
KRM22 PLC
02 April 2020
 

 

 

KRM22 plc

("KRM22", the "Group" or the "Company")

Trading Update

KRM22 plc (AIM: KRM.L), the technology and software investment company that focuses on risk management for capital markets, announces the following trading update for the first quarter of the new financial year and an update on the current and expected impacts of the rapidly changing developments regarding the Coronavirus (COVID-19) pandemic.

Q1 Trading update and COVID-19

During the first quarter of the financial year ending 31 December 2020, the Company has continued to see interest for its software products as referenced in its trading update of 13 January 2020. In the period the Company has won new contracts, including an initial contract with a Tier-1 bank, and a number of multi-year contracts are in advanced stages of negotiation. One of these contracts is with a UK based global brokerage firm which is expected imminently and two further contracts are with Tier-1 banks and if all are signed, are expected to increase ARR by an aggregate of over £0.6m ARR and account for non-recurring revenue of over £0.2m. While the Company has been engaged with the Tier 1 banks for several months and the process with both is advancing, the time to complete the negotiations can be unpredictable. The Company will provide a further update when appropriate.

The Company continues to see strong interest in its risk management offerings however, is also seeing that sales cycles for contracts are extending predominantly due to the high volatility in markets and trading volumes increasing daily workloads at the Company's customers and prospects. In addition to this, the sales cycles are also being impacted by the restrictions implemented by governments across the world pursuant to COVID-19. The Company is fully operational globally from home as a result of the infrastructure and process that were implemented from launch. The Board remains encouraged by the fact that the Company's existing and potential customers remain engaged in discussions on new business, due to the critical nature of the Company's offering. However, visibility on what the full impact COVID-19 will have on the progress of these discussions is limited.

As announced in the trading update of 13 January 2020, £0.3m of ARR was contributed by an existing customer that was acquired by a third party. Unfortunately, as a result of this acquisition the services provided by the Company have been terminated. The Company believes that the customer is in breach of the termination clauses and facilitated an IP infringement. The Company will pursue legal action if required. One customer focused on the crypto-currencies market, has terminated their contract for £0.1m ARR for cost purposes. One additional crypto-currencies market customer, with £0.1m ARR, has requested payment deferral to September 2020 for the same reason and is not contractually entitled to terminate. Despite these impacts, the Company continues to have a strong pipeline of prospects of other opportunities, including crypto venues in addition to the prospects outlined above. The Company remains focused on continuing to drive organic growth during 2020. Excluding the above three contracts, as at today the Company currently has non disputed contracted annual recurring revenue ("ARR") of £4.0m.

Actions taken

The Company has implemented further cost cutting actions which is expected to reduce the overall cost-base of the Group by over £1.0m over twelve months. These measures include salary sacrifices for all staff in 2020, together with general overhead reductions and a decreased spend on travel as a result of the restrictions imposed pursuant to COVID-19. The Company has also agreed to reduce property/office costs by downsizing in London and giving up certain leases in Prague, Chicago and New York. The Board expects arrangements to be completed by July and these property cost savings would amount to approximately £0.3m per annum. The cost reductions will not affect the Company's ability to support its existing customers or win new potential customers. As at July 2020 the total monthly operational cash burn will be £0.1m plus £0.03m cash outflow for Harbert interest and capital repayments.

Financial facilities

Cash at 31 March 2020 was £0.4m (cash as at 31 December 2019: £1.0m). The Board and executive team continue to monitor cash very carefully and have continued to reduce the cost base further, as explained above. The Company is also engaged in discussions with its existing debt facility provider with regards to a further draw-down of cash and expects this to provide £0.5m by the end of June. In addition, the Board will be making a further R&D Tax claim which is expected to be worth approximately £0.5m which, if approved, is expected to be received in August 2020. This is subject to sign off of the Company's final audited accounts for the year ended 31 December 2019.

The Board is aware that strengthening its balance sheet to meet its working capital needs over the next six weeks is critical, particularly in these turbulent and uncertain times. The Company will be talking to existing and potential new shareholders about an equity placement as well as banks about access to government backed loans and in addition to its existing and new debt providers. The Board has committed that it will participate in an equity placement. The Company is also exploring other options to ensure it has alternatives to support its continued growth.

Board changes

As also announced today, Kim Suter, CFO, has been appointed to the Board of Directors and Karen Bach has stepped down from her role as Non-Executive Director. The Board would like to thank Karen for her important role in establishing KRM22 as a business and for her contribution since float.

Outlook

As a result of the many uncertainties and unknowns relating to COVID-19 in terms of timeline and both macro and micro economic consequences, the Board is taking a prudent approach to the growth expected for the year ended 31 December 2020. As a result, the Board anticipates ARR to be significantly lower than management expectations, however as a result of the actions being taken to reduce costs, the Board still expects to be adjusted EBITDA positive by the end of 2020.

 

 

For further information please contact:

 

KRM22 plc InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman and CEO

Kim Suter, CFO

 

finnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Carl Holmes / Kate Bannatyne / Matthew Radley

Alice Lane / Sunila de Silva (ECM)

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimize risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFFFFISRILIII
Date   Source Headline
16th Apr 20247:00 amRNSDirector Dealings
15th Apr 20247:00 amRNSNew Customer Contract
10th Apr 20247:00 amRNSIssue of Equity
7th Mar 20247:00 amRNSBoard Changes
21st Feb 20247:00 amRNSTrading Update
1st Dec 20237:00 amRNSIssue of Restricted Stock Units
26th Sep 20237:00 amRNSInterim Results
27th Jul 202311:48 amRNSResult of General Meeting
21st Jul 20237:00 amRNSDirector Dealing
20th Jul 20237:00 amRNSHalf Year Trading Update
4th Jul 20237:00 amRNSPosting of Accounts, Circular and Notice of GM
30th Jun 202312:41 pmRNSResult of AGM
27th Jun 20237:00 amRNSFinal Results
19th Jun 20237:00 amRNSNew Debt Facility
8th Jun 20237:00 amRNSAnnual Report and Notice of AGM
16th Dec 20223:15 pmRNSIssue of Options
20th Sep 20227:00 amRNSInterim Results
13th Jun 202210:00 amRNSHolding(s) in Company
5th May 202212:00 pmRNSResult of AGM
20th Apr 20222:30 pmRNSDirector Dealing
12th Apr 20227:00 amRNSNotice of AGM and Posting of Annual Report
7th Apr 20224:30 pmRNSHolding(s) in Company
28th Mar 20225:30 pmRNSHolding(s) in Company
23rd Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSProduct Launch Under Distribution Agreement
1st Mar 20227:00 amRNSUpdate re Annual Results (Change of Date)
31st Jan 20227:00 amRNSTrading Update
5th Jan 202210:47 amRNSHolding(s) in Company
30th Dec 20219:47 amRNSSubscription Completion, Executive Changes and TVR
22nd Dec 20217:00 amRNSSubscription Update
22nd Nov 20217:00 amRNSHolding(s) in Company
1st Nov 20217:00 amRNSSubscription Agreement and Trading Update
20th Oct 20213:43 pmRNSHolding(s) in Company
16th Sep 20212:38 pmRNSDirector/PDMR Shareholding
13th Sep 20219:52 amRNSDirector/PDMR Shareholding
10th Sep 20212:48 pmRNSDirector/PDMR Shareholding
8th Sep 202112:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
1st Sep 20217:00 amRNSInterim Results
30th Jul 20217:00 amRNSContract Extension
22nd Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20217:00 amRNSKRM22 announces partnership with Waymark Tech
28th Apr 20211:29 pmRNSResult of AGM
19th Apr 20217:00 amRNSExercise of options and total voting rights
26th Mar 20213:24 pmRNSHolding(s) in Company
23rd Mar 20218:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20215:39 pmRNSHolding(s) in Company
16th Mar 202111:06 amRNSTechnology Demonstration
16th Mar 20217:00 amRNSFinal Results
24th Feb 20217:00 amRNSKRM22 announces new partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.